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1, introduction 
Cancer chemotherapy isbased mainly on agents 
that, although cell-cycle specific inhibitors, do not 
normally show a selective ffect on transformed, as 
opposed to normal-growing, cells [I]_ Under special 
conditions, however, some compounds act selectively 
on transformed cells. For instance, compounds that 
arrest normal cells in the Gl phase of the cell-cycle 
combined with S phase inhibitors selectively kill 
transformed proliferating cells [2-6). Unfortunately, 
many of these selective methods use agents too toxic 
for cancer therapy. 
Several procedures are now available to reversibly 
permeabilize mammalian cells to low molecular weight 
compounds [7,8]. One of these methods, which uses 
ATP combined with a saline buffer, specifically per- 
meabilizes transformed cells [7]. However, both 
normal and transformed cells exposed to the per- 
meabilizing conditions are equally viable when 
replaced in normal culture medium. We reasoned that 
this selective permeabilization could provide a 
method for specifically killing tr~sformed cells with 
inhibitors to which normal or transformed untreated 
cells are normally impermeable. An inhibitor of this 
kind is hygromycin B, an aminoglycoside anti- 
biotic produced by Srreptomyces hygroscopicus. 
Although this compound powerfully blocks protein 
synthesis in cefl-free systems [9], it is ineffective in 
intact mammalian cells, owing to failure to penetrate 
the plasma membrane [IO]. We have shown that this 
antibiotic readily inhibits translation in virus-infected 
cells, as these cells have modified permeability to 
low molecular weight compounds [lo,1 11. 
2. Materials aud methods 
Mouse fibroblasts Balb 3T3 and Kirsten sarcoma 
ElsevierlNorth-~otta~d Biomedicul Press 
~rus-transfo~ed 3T3 cells (K-A3 1) were kindly 
donated by Drs M. Barbacid and S. Aaronson. They 
were propagated inFalcon flasks containing Dulbecco’s 
modified Eagle’s medium supplemented with 10% 
newborn calf serum (Gibco). 
The permeabi~~tion f cells was carried out 
basically as in [7]. For this purpose, 0.5 mM per- 
meabilization buffer (100 mM Tris-HCl (pH 8.2), 
50 mM NaCl, 50 I.~M CaC&, 5 mg dextran/ml, 500 
and 0.5 mM ATP) was added to cells cultured in 
24-well dishes. The permeabili~tion was stopped by 
adding fresh culture medium supplemented with 10% 
newborn calf serum, 
Protein synthesis was estimated by placing the cells 
in methionine-free culture medium supplemented with 
0.5% newborn calf serum. [3SS]Methionine (1000 Ci/ 
mmol; 250 000 ~pm/well) 10 ~1, was added and the 
cells were finally processed by precipitating the cell 
monolayer with 5% trichloroacetic acid, followed 
by 3 washes with ethanol. The cell precipitate was 
dried under an infrared lamp, dissolved in 0.3 ml 0.1 N 
NaOH and radioactivity in 0.150 ml measured in an 
sc~til~tion spectrophotometer. 
3. Results and discussion 
Balb 3T3 and Kirsten sarcoma ~rus-tr~sformed 
Balb 3T3 cells (K-A3 1) were a placed in permeabili- 
zation medium plus ATP in the presence of 0.5 n&i 
hygromycin B for different times. After this treat- 
ment the cells were washed with fresh culture 
medium and protein synthesis was measured. Figure 1 
shows that 5 min treatment was sufficient o block 
protein synthesis almost completely in transformed 
K-A3 I cells, whereas aparallel treatment did not 
affect translation in normal 3T3 cells. Furthermore, 
1 day after this treatment massive mortality of trans- 
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Fig.]. Balb 3T3 and K-A31 cells were cultured in Linbro 
dishes (24 wells) in Dulbecco’s modified Eagle’s medium 
containing 10% calf serum. The cells were permeabilized with 
0.5 ml medium P containing: 100 mM Tris-HCl (pH 8.2), 
50 mM NaCl, 50 PM CaCl,, 5 mg dextranlml, 500 and 
0.5 mM ATP, and 0.5 mM hygromycin B. After treatment at 
37°C for the indicated time 1 ml medium containing 10% 
calf serum was added and 1 h later, the medium was replaced 
by 0.5 ml methionine-free medium containing 0.5% calf 
serum and 10 r.11 [3SS]methionine (1000 Ci/mmol; 250 000 
cpm/well) and the cells were incubated for another 1 h at 
37°C. Finally, the radioactivity incorporated into protein was 
determined as in [ lo]. 
formed cells was observed and, another day later, 
virtually all transformed cells permeabilized in the 
presence of hygromycin B were dead. However, 3T3 
cells continued synthesising proteins at control levels. 
Several experiments were carried out to test the 
effects of different inhibitors, of ATP and of the time 
when hygromycin B was added. Hygromycin B at 
> 0.5 mM was sufficient to kill transformed cells if the 
antibiotic was present for 5-10 min during permea- 
bilization. Moreover, ATP was not an absolute require- 
ment to permeabilize transformed K-A3 1 cells: 40% 
inhibition by hygromycin B was obtained in its 
absence, but 0.1-0.5 mM ATP raised the inhibition 
to 90%. On the other hand, addition of the antibiotic 
with Eagle’s serum-free medium after the permeabili- 
zation period had no effect on protein synthesis by 
K-A31 cells, indicating that the membrane seals 
rapidly after the addition of fresh culture medium. 
The time course of protein synthesis both in 3T3 
and K-A3 1 cells permeabilized in the absence or 
presence of various concentrations of hygromycin B 
is shown in fig.2. Transformed cells treated with 
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Fig.2. Cells, grown as indicated under fig.1, were permea- 
bilized with 0.5 ml medium P, plus 0.1 mM ATP, plus the 
indicated amount of hygromycin B. After 10 min at 37’C, 
the cells were labelled with [3SS]methionine as indicated 
above. (o--o). Control; (~---a) 5 X 10d4M hygromycin B; 
(o--o) 10-s M hygromycin B. 
1 mM hygromycin B during the permeabilization 
period completely stopped the synthesis of new 
proteins 4 h after treatment, whereas 3T3 cells con- 
tinued translation almost at control levels. 
We also tested for the entry of high molecular 
weight inhibitors into transformed cells and found 
that in the presence of 40 pg o-sarcin/ml [ 121 even 
60 min incubation in permeabilizing medium plus 
ATP, failed to block translation in K-A3 1 cells. This 
treatment then, would not seem to render K-A31 
cells permeable to proteins. 
The use of this permeabilisation method opens up 
the possibility of finding a number of selective 
inhibitors for transformed cells. The common require- 
ment for these inhibitors is impermeability to cells 
under normal conditions. Unfortunately, most, if not 
all, anticancer drug screening procedures, discard this 
kind of drug. Although the therapeutical potential of 
this technique is still far from clear, because of the 
conditions used to permeabilize transformed cells, we 
believe it should be possible to find a mild non-toxic 
procedure to permeabilize cancerous cells specifically. 
Such an achievement would provide the rationale for 
a new approach to cancer therapy. 
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